NOAEL Studies
Cosmetic Ingredient
HC Red No. 13 NOAEL Studies
INCI: HC RED NO. 13
CAS: 94158-13-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 75 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCS; Weide, J.; Three-month toxicity test in rats with the test substance Kardinalrot (Part1); WELLA AG; 1985 |
SCCS Opinion 13 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =5 | mg/kg bw | rat | - | 90-day | dermal absorption | p.5 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw | rat | - | 90-day | dermal absorption | p.5 |
| SCCS Opinion | NOAEL | =300 | mg/kg/day | rat | oral | 13 weeks | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =84 | % | rat | oral | 13 weeks | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =300 | mg/kg bw | rat | oral | 90-day | reproductive toxicity | Ref.: 22), p.30 |
| SCCS Opinion | NOAEL | =30 | mg/kg | rat | oral | - | NOAEL study | p.30 |
| SCCS Opinion | NOAEL | =4.2 | mg/kg bw/day | rat | dermal | 90-day | reproductive toxicity | p.33 |
| SCCS Opinion | NOAEL | =300 | mg/kg bw/day | rat | dermal | 90-day | reproductive toxicity | p.33 |
| SCCS Opinion | NOAEL | =10 | - | rat | - | - | NOAEL study | p.21 |
| SCCS Opinion | NOAEL | =5 | mg/kg bw/day | - | - | 34 days | repeated dose toxicity | p.22 |
| SCCS Opinion | NOAEL | =0.011 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.32 |
| SCCS Opinion | NOAEL | =4.2 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.32 |
| SCCS Opinion | NOAEL | =0.01 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.33 |
Regulatory source 21 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 300 | mg/kg/day | rat | oral | 13 weeks | - | p.21 |
| Regulatory source | - | 84 | % | rat | oral | 13 weeks | - | p.22 |
| Regulatory source | - | 30 | mg/kg | rat | oral | - | - | p.30 |
| Regulatory source | - | 300 | mg/kg bw | rat | - | - | - | p.31 |
| Regulatory source | - | 300 | mg/kg bw/day | rat | oral | 13 weeks | - | p.21 |
| Regulatory source | - | 10 | - | rat | - | - | - | p.21 |
| Regulatory source | - | 30 | mg/kg bw/day | rat | oral | - | - | p.30 |
| Regulatory source | - | 300 | mg/kg bw/day | rat | - | - | - | p.31 |
| Regulatory source | dermal absorption | 5 | mg/kg bw | rat | - | 90-day | dermal absorption | p.5 |
| Regulatory source | dermal absorption | 30 | mg/kg bw | rat | - | 90-day | dermal absorption | p.5 |
| Regulatory source | dermal absorption | =0.011 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.32 |
| Regulatory source | dermal absorption | =4.2 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.32 |
| Regulatory source | dermal absorption | =0.01 | mg/kg bw/d | rat | oral | 90 day | dermal absorption | p.33 |
| Regulatory source | repeated dose toxicity | 5 | mg/kg bw/day | - | - | 34 days | repeated dose toxicity | p.22 |
| Regulatory source | reproductive toxicity | 300 | mg/kg bw | rat | oral | 90-day | reproductive toxicity | p.30 |
| Regulatory source | reproductive toxicity | 4.2 | mg/kg bw/day | rat | dermal | 90-day | reproductive toxicity | p.33 |
| Regulatory source | reproductive toxicity | 300 | mg/kg bw/day | rat | dermal | 90-day | reproductive toxicity | p.33 |
| Regulatory source | reproductive toxicity | 300 | mg/kg bw/day | - | - | 90-day | reproductive toxicity | p.29 |
| Regulatory source | reproductive toxicity | 5 | mg/kg bw/day | rat | dermal | - | reproductive toxicity | p.33 |
| Regulatory source | reproductive toxicity | 4.2 | mg/kg bw/day | rat | dermal | - | reproductive toxicity | p.33 |
| Regulatory source | reproductive toxicity | 300 | mg/kg bw/day | rat | dermal | - | reproductive toxicity | p.33 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 3S057K0K0B | UNII | - | - | - | chemical | - |